Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/12/970   
Active ingredient: 6-ethynyl-1-(pentan-3-yl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: ICON Clinical Research (U.K.) Limited
Regulatory Division, 2 Globeside, Globeside Business Park, Marlow, Buckinghamshire SL7 1HZ, United Kingdom

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/03/2012 Centralised Orphan - Designation EMA/OD/138/11 (2012)1535 of 05/03/2012